Taysha Gene Therapies, INC. (TSHA) — DEF 14A Filings

All DEF 14A filings from Taysha Gene Therapies, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.

DEF 14A Filings (2)

Taysha Gene Therapies Files 2025 Proxy Statement — Apr 21, 2025 Risk: low
Taysha Gene Therapies, Inc. filed its definitive proxy statement on April 21, 2025, for its annual meeting on June 2, 2025. The filing covers the fiscal year en
Taysha Gene Therapies Announces 2024 Annual Meeting of Stockholders — Apr 18, 2024 Risk: low
Taysha Gene Therapies, Inc. (TSHA) filed a Proxy Statement (DEF 14A) with the SEC on April 18, 2024. Annual Meeting scheduled for May 29, 2024, at 3:00 p.m. ET,

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX